The objective of the study is to investigate the effect of nutritional supplementation with eicosapentaenoic acid (EPA)-enriched formula on the inflammatory profile of patients with oral cavity cancer. The study was conducted with 53 patients with oral cavity cancer in antineoplastic pretreatment who were randomized into two groups: the control group received a powdered supplement without EPA during 4 wk and the intervention group received a liquid supplement enriched with EPA (2 g/day) during the same period. In the baseline and after 4 wk of supplementation, serum concentrations of albumin, prealbumin, C-reactive protein (CRP), and interleukin-6 (IL-6) were measured. Values of CRP and of CRP/albumin ratio were lower in the intervention group than those in the control group. However, when the two groups were compared to each other after intervention, any significant difference was not observed. There was a significant negative correlation between levels of CRP and albumin, and IL-6 and albumin, both in the control and in the intervention groups. In both groups, a positive correlation between concentrations of IL-6 and CRP was observed. No significant difference was encountered in the assessed parameters between the group that received standard supplement and the group that received EPA-enriched supplement.
Introdução: O câncer de cavidade oral é considerado um problema de saúde pública no mundo. A desnutrição é prevalente nessa população, aumentando a morbimortalidade. A suplementação com ácido eicosapentaenoico tem sido proposta para reverter o catabolismo proteico e modular processos inflamatórios. Objetivo: Avaliar o efeito do suplemento nutricional enriquecido com ácido eicosapentaenoico no peso corporal e massa magra de pacientes com câncer de cavidade oral. Método: Ensaio clínico realizado com pacientes em pré-tratamento oncológico. Os pacientes foram randomizados para receber suplemento nutricional com ácido eicosapentaenoico (2 g/dia) ou placebo. Os parâmetros nutricionais (peso, estatura, composição corporal e ingestão alimentar) foram avaliados no início (T0) e após quatro semanas de suplementação (T1). O teste-t pareado ou de Wilcoxon foram usados nas comparações intragrupos. As associações entre as variáveis categóricas foram verificadas por meio do teste do χ² ou Exato de Fisher. A regressão logística foi aplicada para identificar a chance de perder peso. As diferenças foram consideradas significativas quando p<0,05. Resultados: Não foi observada diferença significativa nos parâmetros nutricionais entre os grupos após a intervenção. No entanto, considerando cada grupo no início e no final do estudo, observou-se que os pacientes do grupo controle apresentaram perda de peso significativa (T0: 57,2 kg x T1: 56,4 kg), redução no índice de massa corporal (T0: 22,6 kg/m2 x T1: 22,0 kg/m2), massa gorda (T0: 17,3 kg x T1: 15,3 kg) e circunferência do braço (T0: 27,4 cm x T1: 26,8 cm). Aqueles que receberam suplemento com ácido eicosapentaenoico tiveram 80% menos chance de perder peso (95% IC: 0,045-0,860; OR: 0,19). Conclusão: Este estudo produziu dados que sugerem que pacientes com câncer de cavidade oral podem se beneficiar com o uso de suplemento nutricional contendo ácido eicosapentaenoico no pré-tratamento oncológico. Número de Registro: U1111-1177-3678.
Objective: To estimate Age-Period-Cohort effects on colorectal, colon and rectal cancer incidence rates in Latin American countries covered by high quality Population-Based Cancer Registries. Methods: A trend study was performed using data from Cancer Incidence in Five Continents. Age-Period-Cohort effects were estimated by Poisson regression for individuals aged between 20 and 79 years with colorectal, colon and rectal cancers informed by Population-Based Cancer Registries from 1983 to 2012 in Cali (Colombia); from 1983 to 2007 in Costa Rica; and from 1988 to 2012 for both Goiânia (Brazil) and Quito (Ecuador). Goodness of fit model was tested using the deviance of the models. Results: Age effect was statistically significant for both sexes in all Population-Based Cancer Registries areas and the curves slope reached peaks in the older age groups. There were cohort effects on the incidence rates for colorectal, colon and rectal cancers in all Population-Based Cancer Registries areas, except for women in Quito. Regarding the period effect, an increased ratio rate was observed in men (1.26, 95%CI 1.17 to 1.35) and women (1.23, 95%CI, 1.15 to 1.32) in Goiânia, between 2003 and 2007. Conclusions: In Latin America, age effect was observed on incidence rates for colorectal, colon and rectal cancers. Besides, birth cohort effect was identified for recent cohorts in both genders for colorectal, colon and rectal cancers in Cali and Goiânia, and cohort effect for colorectal and colon cancers in both genders in Costa Rica; while in Quito a cohort effect was only observed for rectal cancer among men. Period effect was observed in Goiânia with increased ratio rate in 2003-2007.
This study aimed to assess time trends in colorectal cancer incidence from 1983 to 2012 in Latin America. This was an ecological time-series study whose population consisted of individuals aged 20 years or older diagnosed with colorectal cancer. Data from population-based cancer registries in Cali (Colombia), Costa Rica, Goiânia (Brazil), and Quito (Ecuador), were used for rates estimation, while time trends estimations were proceeded by the Joinpoint Regression Program. The study showed an increase in colorectal cancer incidence in men and women in Cali (2.8% and 3.2%, respectively), Costa Rica (3.1% and 2.1%, respectively), and Quito (2.6% and 1.2%, respectively), whereas in Goiânia, only women showed an increase in colorectal cancer rates (3.3%). For colon cancer, we observed an increasing trend in incidence rates in men and women in Cali (3.1% and 2.9%, respectively), Costa Rica (3.9% and 2.8%, respectively), and Quito (2.9% and 1.8%). For rectal cancer, we observed an increasing trend in incidence in men and women in Cali (2.5% and 2.6%, respectively), Costa Rica (2.2% and 1%, respectively), and Goiânia (5.5% and 4.6%, respectively), while in Quito only men showed an upward trend (2.8%). The study found increases in colorectal cancer, colon cancer, and rectal cancer in four Latin America regions. This findings reflect lifestyle, such as dietary changes, following the economic opening, and the prevalence variations of colorectal cancer risk factors by sex and between the four studied regions. Finally, the different strategies adopted by regions for colorectal cancer diagnosis and screening seem to influence the observed variation between anatomical sites.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.